Study: Depression, Anxiety More Frequently Diagnosed in Women
November 9th 2020The processes involving the high prevalence of diagnosis and over prescription undoubtedly play a role, but it is possible that the infra-diagnosis and lower prescription rates in men could be a factor, according to the study authors.
Read More
FDA Committee Does Not Recommend Approval of Aducanumab for Alzheimer Disease
November 9th 2020A final vote that assessed whether the findings from the EMERGE trial served as primary evidence for the efficacy of aducanumab in Alzheimer disease was 10–0 that the trial did not provide evidence.
Read More
Combo Drug Treatment for Type 2 Diabetes Remains Effective After 2 Years
November 6th 2020The drug combination of dapagliflozin and exenatide continues to stay effective without a loss of effect after 2 years of continual use in patients with type 2 diabetes (T2D), according to researchers at Thomas Jefferson University.
Read More
Study: Excessive Alcohol Consumption During the COVID-19 Pandemic
November 5th 2020The greater effect on population-wide alcohol use could be tied to the effects of the COVID-19 pandemic, including widespread social disruption and isolation, limited social support and access to medical care, and negative domestic and global economic impacts.
Read More
Study Supports Use of Radiation Before CAR-T Cell Therapy for Multiple Myeloma
November 5th 2020The study found patients who received radiation 34 days or fewer before their infusion with CART-B cell maturation antigen (BCMA) cells did not have worse rates of severe cytokine release syndrome or neurotoxicity, which are 2 common adverse effects of the cellular therapy.
Read More
Study: Black Women More Likely to Experience Delays in Breast Cancer Treatment
November 5th 2020Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.
Read More
New Migraine Drugs Target Triptan Contraindication Population
November 5th 2020The current acute treatments for migraines have shown efficacy and safety, however, approximately one-third of people do not respond, cannot use these options due to contraindications, or report dissatisfaction in therapy.
Read More